Schedule 13G ownership disclosure

Sagimet Biosciences Inc

Security class unavailable · CUSIP: 786700104

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,468,128
Percent of class
8.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006666
Form type
SC 13G/A
Filer
Point72 Asset Management, L.P.
CIK
CIK 1603466
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub